Epithelial cells provide an initial line of defense against damage and pathogens in barrier tissues such as the skin; however this balance is disrupted in obesity and metabolic disease. Skin cd T cells recognize epithelial damage, and release cytokines and growth factors that facilitate wound repair. We report here that hyperglycemia results in impaired skin cd T cell proliferation due to altered STAT5 signaling, ultimately resulting in half the number of cd T cells populating the epidermis. Skin cd T cells that overcome this hyperglycemic state are unresponsive to epithelial cell damage due to chronic inflammatory mediators, including TNFa. Cytokine and growth factor production at the site of tissue damage was partially restored by administering neutralizing TNFa antibodies in vivo. Thus, metabolic disease negatively impacts homeostasis and functionality of skin cd T cells, rendering host defense mechanisms vulnerable to injury and infection.
Introduction
Resident intraepithelial cd T cells are responsible for maintaining epithelial integrity, regulating homeostasis and providing a first line of defense against pathogens and injury in mice and humans [1, 2, 3] . cd T cells arise in the thymus during ontogeny and migrate, in waves, to epithelial tissues such as the skin, lung, intestine and reproductive tract where they populate these tissues for the life of the animal [4, 5] . In addition to their role in the innate immune response, cd T cells regulate the subsequent recruitment of inflammatory cells to sites of injury and infection [6, 7, 8] . Murine skin resident T cells express a canonical Vc3Vd1 T cell receptor (TCR) and respond to a proposed, yet unknown, self antigen expressed by stressed or damaged keratinocytes [9, 10] . Skin cd T cells display a dendritic morphology, retract their dendrites following activation and are critical for epidermal homeostasis and wound repair through their production of cytokines and regulation of inflammatory cells [1, 6, 11, 12, 13, 14, 15] . Mice deficient in cd T cells exhibit disrupted skin homeostasis, impaired barrier function and delayed wound healing [1, 15, 16, 17] . In humans, the epidermis consists of a mixed resident ab and cd T cell population [18] . Similar to observations in mice, skin-resident Vd1
+ cd T cells in humans produce cytokines and growth factors after activation and participate in wound repair [19] .
In obesity and metabolic syndrome, the epidermal barrier is disrupted and skin complications can ultimately result in chronic and debilitating non-healing wounds and persistent infections [20] . Chronic wounds in obese and diabetic patients show diminished or altered levels of growth factors, impaired leukocyte infiltration and function and the absence of cell growth and migration over the wound [20] . Even with medical treatment, these chronic non-healing wounds may ultimately result in amputation of extremities [21] . Recent work has focused on the initiation of chronic inflammation in adipose tissue in obesity. An increase in effector CD8
+ T cells and a decrease in CD4 + and T regulatory cells in adipose tissue have been shown to correlate with exacerbated adipocyte inflammation and metabolic disease progression [22, 23, 24] . However, the consequence of obesity and metabolic disease on the function of skin resident lymphocyte populations and how this contributes to skin complications associated with obesity and metabolic disease are unknown.
In this study we investigated how skin cd T cell function becomes altered in obesity and metabolic disease. We show that the progression of metabolic disease impacts both the homeostasis and wound healing response of skin cd T cells. Correlating with early hyperglycemia, the proliferation of skin cd T cells is impaired, which ultimately results in a reduction in tissue-resident epidermal T cell numbers. The remaining skin cd T cells overcome this hyperglycemic state, but exhibit altered metabolic and nutrient sensing pathways. The chronic inflammatory environment, specifically elevated TNFa, renders the remaining skin cd T cells dysfunctional to tissue damage. In this inflammatory environment, skin cd T cells are unresponsive to keratinocyte stimulation and unable to produce cytokines and epithelial regulating factors such as TGFb1. We can improve skin cd T cells function in vivo by blocking TNFa, providing evidence that chronic TNFa in metabolic syndrome contributes to skin cd T cell dysfunction in wound healing.
Results

Skin cd T cells are unable to maintain epidermal numbers in obesity
Skin cd T cells arise in the thymus during fetal development, migrate to the skin and actively expand to reach a maximum of ,5% of the total cells in the epidermis. After this early migration, the epidermal skin cd T cell compartment is maintained through self-renewal. To determine the impact of obesity and metabolic disease on skin cd T cell survival and maintenance, we quantified cd T cell numbers in epidermal sheets and analyzed their morphology starting at 6-weeks of age and continuing out to 14-weeks of age. Epidermal sheets from 6-week old db/+ (lean control) and db/db mice demonstrated that skin cd T cells seeded the epidermis, were present in expected numbers and exhibited their characteristic dendritic morphology ( Figure 1A) . However, at this 6-week time point, a slight decrease in cd T cell numbers was observed. By 8-and 10-weeks of age a pronounced decrease in skin cd T cell numbers was apparent in obese db/db mice ( Figure 1A and 1B) . Following this rapid decline, epidermal cd T cells stabilized at 10-weeks of age and remained reduced out to 14-weeks of age ( Figure 1A and 1B) .
In addition to the lymphocyte population, a resident dendritic cell population, the Langerhans cells (LC), also resides in the skin. To determine the impact of obesity and metabolic disease on another skin-resident immune population, we examined LC numbers using anti-langerin and anti-CD45.2 antibodies to stain epidermal sheets [25] . Obese db/db mice had similar numbers of LC in the epidermis as compared to lean db/+ control mice at all ages tested ( Figure 1C and 1D ). Our data suggest that the early progression of obesity and metabolic syndrome are marked by a selective inability of skin cd T cells to maintain homeostatic numbers within the epidermis.
To address the possible contribution of leptin receptor deficiency on skin cd T cells from db/db animals, we investigated the expression of leptin (Lep) and two leptin receptor isoforms (Lepr) in skin cd T cells. No expression of either leptin or two leptin receptor isoforms, Ob-Ra and Ob-Rb, was detected in mRNA from skin cd T cells isolated directly ex vivo or in the cd 7-17 cell line in vivo ( Figure S1 ).
Hyperglycemia alters STAT5 signaling and impedes cd T cell proliferation
Between 6-and 10-weeks of age, BKS db/db mice are hyperglycemic and exhibit greater weight gain than their db/+ control littermates (Table S1) . To determine the impact of environmental factors that are present during this phase of disease, such as glucose and fatty acids, we tested whether the 7-17 skin cd T cell line can maintain itself and survive when these factors are present and elevated. We found that 7-17 cd T cells treated with 33.3 mM glucose resulted in a rapid decline of T cells within 24 to 48 hours of treatment ( Figure 2A) . However, treatment of 7-17 cd T cells with fatty acids did not inhibit cd T cell growth ( Figure  S2) .
To investigate the impact of glucose on skin cd T cell proliferation, 7-17 cells were maintained in IL-2, treated with elevated glucose and proliferation determined. As shown in Figure 2B , there was a dose dependent inhibition of cd T cell proliferation 36 hours post-glucose treatment. In addition to the 7-17 cd T cell line, freshly isolated skin cd T cells were sorted from epidermal cell preparations from wild-type mice, placed into IL-2 containing media in the presence of baseline (11.2 mM) or elevated (33.3 mM) glucose. Similar to observations with the 7-17 cd T cell line, freshly isolated skin cd T cells also displayed reduced proliferation in the presence of elevated glucose ( Figure 2C ). This data suggests that skin cd T cells are highly sensitive to elevations in glucose, affecting their ability to proliferate and maintain homeostatic numbers.
Since cd T cells proliferate after stimulation with IL-2 in a glucose-sensitive manner, we next asked whether glucose treatment alters downstream IL-2 signaling. IL-2 receptor binding results in Jak1 and Jak3 activation, phosphorylation of STAT5 and translocation of the STAT5 complex to the nucleus where it regulates gene transcription [26] . Following stimulation of untreated skin cd T cells with IL-2, phosphorylation of STAT5A and STAT5B peaked at 30 minutes, followed by a rapid decrease in phosphorylation ( Figure 2D ). However, in glucose-treated cd T cells, STAT5A was rapidly phosphorylated to peak levels within 10 to 30 minutes after IL-2 stimulation but displayed altered kinetics and prolonged phosphorylation compared to untreated cells. In addition, glucose-treated cd T cells had negligible phosphorylation of STAT5B after IL-2 stimulation ( Figure 2D ). This data suggests that diminished proliferation of skin cd T cells may be due to altered IL-2 and STAT5 signaling in response to hyperglycemic conditions. Moreover, STAT5A/B signaling is critical to cd T cell function as cd T cells are absent in mice deficient in STAT5A/B [27] .
To determine if diminished skin cd T cell proliferation in BKS db/db mice accounts for the reduction in epidermal T cell numbers, we first had to investigate the rate of cd T cell proliferation in vivo. Although long-lived, memory-like Vc2 + T cells in the periphery have been shown to have very slow turnover [28] , the rate of Vc3 + T cell proliferation and homeostatic maintenance in the epidermis has yet to be defined. Unlike the rapid turnover of epithelial keratinocytes [29, 30, 31] , LC turnover is much slower, between 5 and 10% of cells proliferating per week [32, 33] . To determine the rate of cd T cell proliferation in the epidermis, control BKS db/+ mice were treated for one week with BrdU in the drinking water and skin cd T cells were analyzed for BrdU incorporation at 6-and 10-weeks of age. Skin cd T cell proliferation in 6-and 10-week old lean db/+ mice averaged approximately 11% of the total cells proliferating per week ( Figure 2E , left panels).
BrdU incorporation was then quantified in 6-and 10-week old BKS db/db mice to ascertain whether decreased proliferation accounts for diminished skin cd T cell numbers in the db/db mouse. In contrast to the 10-12% BrdU incorporation of skin cd T cells in 6-week old lean db/+ mice, only half as many cd T cells incorporated BrdU in db/db mice ( Figure 2E , right panel, and 2F). This reduced percentage of cd T cells isolated from 6-week old db/db mice indicates decreased skin cd T cell turnover in the BKS db/db mouse. Turnover of epithelial keratinocytes confirmed that BrdU was reaching the skin and being incorporated at a similar rate in 6-week old BKS db/+ and db/db ( Figure 2G) . In contrast to 6-week old mice, skin cd T cells from obese 10-week old db/db mice had a similar percentage of skin cd T cells incorporating BrdU as compared to control db/+ mice ( Figure 2E , right panel, and 2F). This correlates with the data presented in Figure 1B , which shows that cd T cell numbers stabilize in 10-week old db/db mice.
To confirm that skin cd T cells were not undergoing increased apoptosis in BKS db/db mice, freshly isolated cd T cells from the epidermis were stained with annexin-V and subject to propidium iodide incorporation (PI). No significant changes in skin cd T cell annexin + PI + populations were detected between lean db/+ and obese db/db animals at multiple ages ( Figure S3A) . Furthermore, to verify that skin cd T cells in the obese environment were not migrating out of the epidermis, whole skin cross-sections were stained with cd TCR-specific antibodies and analyzed by immunofluorescent microscopy. We established that cd T cells in the BKS db/db mouse remained localized to the epidermis and hair follicles ( Figure S3B ) and were not found migrating into the dermis. Additionally, skin-specific Vc3 + T cells were not detected in lymph nodes providing further evidence that they have not migrated out of the epidermis ( Figure S3C) .
Taken together, this data demonstrates that hyperglycemia impacts skin cd T cell proliferation, specifically at 6-weeks of age, ultimately reducing the population of skin cd T cells in the epidermis by half. However, by 10-weeks of age, the remaining skin cd T cells in the db/db animals have overcome the impaired proliferation induced by hyperglycemia.
Skin cd T cells are unresponsive to tissue damage in obesity
Since a population of skin cd T cells survived the hyperglycemic environment, we next asked whether the remaining skin cd T cells in the 10-week old db/db mice were able to respond to epithelial damage in vivo. One major function of skin cd T cells is to recognize epithelial tissue damage and release cytokines and growth factors that facilitate wound repair. To investigate whether the remaining skin cd T cells in the obese mouse are able to rapidly respond following injury, we monitored the ability of skin cd T cells to retract their dendrites at the wound edge. Following injury and activation through their TCR, cd T cells round-up at the wound edge and lose their dendritic morphology [1] . Cells distal to the wound site remain dendritic [1] , confirming that this is a localized response to tissue damage. Full-thickness punch biopsy wounds were performed on obese 10-to 14-week old BKS db/db mice and skin cd T cell morphology was examined at various time points by immunofluorescent microscopy. Our data indicates that skin cd T cells in the obese db/db mice were delayed in their ability to round following wounding as compared to lean db/+ control mice ( Figure 3A) . These results were confirmed by quantifying the number of cd T cells having retracted all their dendrites ( Figure 3B ).
Another characteristic feature of skin cd T cell activation is the upregulation of several Th1-type proinflammatory cytokines, including TNFa [34] . To determine if skin cd T cells in obese mice have lost their ability to produce cytokines, we examined TNFa production by cd T cells located along the wound edge. Full-thickness punch biopsy wounds were performed, cd T cells were isolated from the wound edge, treated with brefeldin A and immediately stained using intracellular cytokine staining. This technique allows for the examination of skin cd T cell function immediately ex vivo without any additional stimulus beyond the wound. In wild-type mice, cytokine production (using TNFa as a readout) was upregulated in skin cd T cells directly adjacent to the wound site in control BKS db/+ mice ( Figure 3C ). However, cd T cells isolated from the wounds of obese 10-to 14-week old BKS db/db mice did not produce TNFa ( Figure 3C ).
We confirmed our in vivo wound healing results in another mouse model of obesity, the diet-induced obesity (DIO) model. C57BL/6J mice were started on a 60% kcal fat diet (B6 HFD) at 6 weeks of age compared to the normal chow diet (B6 NCD) ( Table  S1 ). As shown in Figure 3D , cd T cells isolated from B6 NCD mice upregulated TNFa production at the wound edge compared to non-wounded controls. However, similar to BKS db/db animals, skin cd T cells isolated from 26-to 32-week old B6 HFD mice had little upregulation of TNFa at the wound edge ( Figure 3D ).
In addition to early release of proinflammatory molecules, growth factor production is another key function of skin cd T cells in response to epithelial damage. We therefore reasoned that this functional response of skin cd T cells was likely to be disrupted in skin cd T cells in the obese environment. To address this directly, we investigated intracellular TGFb1 production in skin cd T cells isolated from wounded lean control and obese animals. Skin cd T cells from control 10-to 14-week old BKS db/+ animals increased TGFb1 production at the wound edge 24 hours post-wounding ( Figure 3E ). However, skin cd T cells from obese 10-to 14-week old db/db mice had little to no upregulation in TGFb1 expression ( Figure 3E ). This defective TGFb1 production was confirmed in our second model of obesity, the DIO model. Skin cd T cells isolated from the wound edge of B6 NCD mice upregulated TGFb1 production, however, skin cd T cells isolated from the wound edge of 26-to 32-week old B6 HFD mice had impaired TGFb1 upregulation ( Figure 3F ). Therefore, in addition to defective cytokine production, skin cd T cells in obesity and metabolic disease were unable to upregulate TGFb1 production at the wound edge, an important growth factor in several aspects of wound repair.
Delayed rounding and the inability of skin cd T cells to produce cytokines at the wound edge only occurred in obese 10-to 14-week old db/db animals. Skin cd T cells in 6-week old db/+ and db/db mice retracted their dendrites similarly within 4 hours post wounding and were able to upregulate TNFa adjacent to the wound edge (data not shown). Together, this data suggests two separate stages of disease: 1) an early defect in skin cd T cell proliferation due to hyperglycemia that eventually results in half the number of skin cd T cells residing in the epidermis and 2) a later defect characterized by the inability of skin cd T cells to perform tissue repair functions in vivo.
Impaired skin cd T cell nutrient sensing and activation in obesity
The inability of skin cd T cells to be activated and produce cytokines and growth factors following epithelial damage occurred only in 10-to 14-week old BKS db/db and not 6-week old mice. This unresponsive state was not caused by hyperglycemia and suggests that other environmental factors, such as chronic inflammatory factors, or cell-intrinsic factors may be responsible for the lack of tissue damage responses. To better understand the impact of metabolic disease on skin cd T cells, we performed microarray analysis on skin cd T cells sorted from total epidermal cell preparations from 10-week old BKS lean db/+ and obese db/ db mice.
Based on the gene array, we found that skin cd T cells differentially express NR4A1 and NR4A3, two orphan nuclear receptors which have been shown to sensitize muscle to insulin and have been reported to be underexpressed in obesity and type 2 diabetes [35] . We observed reduced expression of both NR4A1 and NR4A3 in cd T cells isolated from obese db/db mice ( Figure 4A ), suggesting that skin cd T cells residing in db/db animals have decreased insulin sensitivity. Additionally, Pdk1, a central molecule that regulates Akt function, and two members of the mTORC2 complex, Rictor and Sin 1 (Mapkap1), all display decreased gene expression in skin cd T cells isolated from obese db/db mice ( Figure 4B ). Together these genes, which are necessary for the growth and function of cd T cells [36] , were altered in obese mice and reveal a breakdown in the normal signaling pathways required for skin cd T cells homeostasis and function. A breakdown in skin cd T cell signaling pathways may result in changes to their characteristic innate T cell phenotype and function. Skin cd T cells express a Vc3Vd1 TCR and constitutively elevated levels of the activation markers CD69 and CD25 (IL-2 receptor a), suggesting that they are primed to rapidly respond to TCR-mediated activation and growth factors, such as IL-2 [1, 36, 37] . No changes were observed in the expression of activation markers on skin cd T cells isolated from 6-week old BKS db/+ and db/db mice ( Figure S4A ). However, in obese db/db mice at 10-weeks of age, skin cd T cells reproducibly displayed diminished levels of CD69, CD25 and CD103 ( Figure 4C ). Furthermore, cd TCR expression was reproducibly decreased in 10-week old obese db/db mice ( Figure 4D ), but no decrease in cd TCR expression was observed in 6-week old db/db mice ( Figure  S4B ). Decreased expression of activation markers and cd TCR may be due to overstimulation by stressed keratinocytes in obesity and metabolic disease.
cd TCR does not contribute to epidermal T cell dysfunction in obesity
To investigate the contribution of the cd TCR to the hyporesponsive state of skin cd T cells in obesity, we crossed B6 d 2/2 and B6 db/+ animals to generate mice lacking cd TCR that develop obesity and metabolic disease ( Figure 5A ). The epidermis of cd T cell knockout mice (d 2/2 ) lacks Vc3 + T cells but does have an ab T cell population that takes up residence, however, these ab T cells do not respond to keratinocyte damage [37] . No differences in breeding, litter size or growth of the animals were observed in the B6 d 2/2 db/db mice as compared to B6 db/db animals. Both male and female B6 d 2/2 db/db mice gained weight and became obese similar to B6 db/db mice ( Figure 5B) .
To determine the impact of the cd TCR on maintenance of homeostatic numbers of epidermal T cells in d 2/2 db/db animals, epidermal ab T cells were visualized using immunofluorescent microscopy. In both d 2/2 db/+ control and d 2/2 db/db mice, the only T cell population in the epidermis was CD3 + ab T cells; no cd T cells or other CD3
+ populations were present, similar to the epidermal T cell makeup of B6 d 2/2 mice (data not shown). However, in 14-week old obese d 2/2 db/db mice there were ,30% fewer epidermal ab T cells compared with lean d 2/2 db/+ control animals ( Figure 5C ). This suggests that the keratinocyte antigen-specific cd TCR is not necessary for the decline in epidermal T cell numbers observed in obesity.
Although the epidermal ab T cells identified in B6 d 2/2 mice are not responsive to keratinocyte damage, they do express the activation markers CD69, CD25 and CD103 similar to cd T cells in the skin [37] . Since expression of these molecules was diminished on cd T cells in the obese environment, we determined whether activation markers on epidermal ab T cells in the B6 d 2/2 db/db mouse were similarly affected. Decreased expression of both CD69 ( Figure 5D ) and CD25 (data not shown) was observed on epidermal ab T cells in 14-week old obese B6 d 2/2 db/db mouse similar to that observed on epidermal cd T cells in obese B6 db/db mice. Together, this data suggests that the hyporesponsiveness observed in cd T cells of obese mice is not TCR mediated or a direct consequence of overactivation by stressed keratinocytes. Therefore, dysfunction of skin cd T cells in obesity and metabolic disease may be a direct consequence of the inflammatory milieu of the obese environment.
Rescue of skin cd T cell function ex vivo
If the environment in obesity and metabolic disease contributes to skin cd T cell dysfunction, we hypothesized that removal from this environment would improve skin cd T cell function. To investigate whether the response of skin cd T cells in obese mice can be restored by removal from their environment, we isolated epidermal sheets from 10-to 14-week old obese BKS db/db mice and lean db/+ controls and stimulated the skin-resident T cells in vitro with anti-CD3e antibody. After 6 hours in culture, we visualized epidermal sheets by immunofluorescent microscopy and quantified the number of dendrites per cell to determine cellular rounding after stimulation. The majority of cd T cells in unstimulated epidermal sheets exhibited 3 or more dendrites per cell ( Figure 6A ). However, after anti-CD3e stimulation, cd T cells began to round up similarly in epidermal sheets isolated from obese db/db and control db/+ mice, as indicated by the reduced number of skin cd T cells with 3 or more dendrites per cell ( Figure 6A and 6B ). This indicates that removing epidermal cells from the obese db/db mouse, where they were unable to round upon wounding, restores the ability of cd T cells to respond to stimulation.
Since stimulating epidermal sheets from obese db/db mice ex vivo restored the ability of skin cd T cells to round, we next identified whether other cd T cell functions could be rescued as well. To determine if cytokine production could be restored by removing cd T cells from the obese environment, we isolated epidermal cells from 10-to 14-week old BKS lean db/+ and obese db/db mice and cultured them in plates either coated with PBS (unstimulated) or anti-CD3e antibody. Strikingly, upon removal from the obese environment, anti-CD3e stimulated skin cd T cells from obese db/ db mice were able to produce cytokines, such as TNFa, and upregulate the activation marker CD25 to a similar degree as skin cd T cells isolated from control db/+ animals ( Figure 6C ).
Together, these data demonstrate that the dysfunction of skin cd T cells in the obese db/db mouse is not permanent. It suggests that by removing extrinsic factors present in obesity and metabolic disease through the isolation of these cells from the epidermis, the hyporesponsive state of skin cd T cells can be reversed.
Blocking TNFa in obese mice restores skin cd T cell function in epithelial repair
Increased plasma TNFa levels correlate with obesity and insulin resistance in both humans and animals [38] . Our microarray data revealed that several members of the TNFa signaling pathway were increased in skin cd T cells isolated from obese db/db mice, including Traf2, Tradd and Ripk1 ( Figure 7A) , which lead to activation of NF-kB and Jun N-terminal kinase (JNK) [39] . As 
old lean BKS db/+ and obese db/db mice four hours post-wounding. The white dashed line represents the wound edge and arrowheads depict cd T cells that have rounded near the wound edge. A minimum of 10 images was acquired at the wound edge for each experiment and the number of dendrites was determined per cell, a minimum of 300 total cells were counted. (B) Shown is the percentage of cd T cells with 0 dendrites per cell (mean 6 SEM). All images were acquired at 6200 magnification. (C, D) Skin cd T cell production of TNFa in non-wounded and wounded skin tissue of (C) 12-week old BKS db/+ and db/db mice and (D) 27-week old B6 NCD and HFD mice. The numbers represent the percentage of cells expressing TNFa. Skin cd T cell production of TGFb1 in non-wounded and wounded skin tissue of (E) 12-week old BKS db/+ and db/db mice and (F) 27 . The obese environment inhibits skin cd T cell function. (A) Skin cd T cell morphology changes in epidermal sheets isolated from 10-to 14-week old BKS db/+ and db/db following in vitro stimulation with 10 mg/ml anti-CD3e antibody compared to unstimulated control. All microscopy images were acquired at 6200 and the bar represents 0.05 mm. (B) Shown is a graphical representation of the percentage of skin cd T cells with 0, 1, 2 or $3 dendrites, which represent the degree of cd T cell rounding (mean 6 SEM), in epidermal ear sheets from 10-to 14-week old BKS db/+ and obese db/db animals stimulated with 10 mg/ml anti-CD3e antibody. Three independent experiments were performed, a minimum of 10 fields were counted for each, and this data represents the average of all 35 fields and approximately 1000 total cells. (C) Multiparameter flow cytometry of TNFa production and CD25 expression by cd T cells isolated from 10-to 14-week old BKS db/+ and db/db mice following overnight stimulation with 1 mg/ml anti-CD3e. Numbers in the upper right corner indicate percent cd T cells. Epidermal cells gated on live Thy1.2 + events. Data are representative of at least three independent experiments. doi:10.1371/journal.pone.0011422.g006 Figure 7 . Neutralization of TNFa rescues skin cd T cell function at the wound site. (A, B) Microarray analysis of skin cd T cells isolated from 10-week old BKS db/+ and obese db/db mice. Shown is gene expression of molecules associated with TNFa signaling. Data is presented as the mean of two independent experiments 6 SEM. (C) Epidermal sheets isolated from 10-to 14-week old BKS db/+ and obese db/db animals either unstimulated or stimulated with 10 mg/ml anti-CD3e antibody and 100 ng/ml TNFa. All microscopy images were acquired at 6200 and the bar represents 0.05 mm. (D) Quantification of the percentage of skin cd T cells with 0, 1, 2 or $3 dendrites, which represent the degree of cd T cell rounding (mean 6 SEM), in epidermal ear sheets from 10-to 14-week old BKS db/+ and obese db/db animals stimulated with 10 mg/ml anti-CD3e shown in Figure 7B , downstream molecules contributing to survival, such as Birc5 (survivin), are increased in skin cd T cells isolated from obese db/db animals. However, molecules that negatively regulate Ripk1 and Jnk signaling, such as Tnfaip3 (A20) and GADD45b respectively [40] , are decreased in cd T cells isolated from obese db/db mice.
Since elevated gene expression of TNFa signaling molecules was observed in skin cd T cells isolated from obese db/db mice, we set out to determine the consequence of elevated and chronic TNFa levels on skin cd T cell function. Exogenous TNFa was added to cultured epidermal sheets isolated from control and obese animals. If TNFa alone contributes to the suppressive inflammatory milieu, skin cd T cells would remain impaired upon ex vivo stimulation in the presence of this cytokine. Epidermal sheets from 10-to 14-week old lean db/+ mice, which have not been exposed to chronic TNFa in their environment, rounded when stimulated with anti-CD3e antibody in the presence of acute TNFa ( Figure 7C and 7D) . However, cd T cells in epidermal sheets isolated from obese db/db animals, which have been exposed to elevated and chronic TNFa in their environment, displayed delayed rounding when stimulated with anti-CD3e antibody only if TNFa was present ( Figure 7C and 7D) . As shown in Figure 6A , epidermal sheets from obese db/db mice were able to round following stimulation with anti-CD3e antibody alone. This suggests that TNFa alone alters the ability of skin cd T cells to round following stimulation, providing a mechanism for skin cd T cell dysfunction.
Due to the contribution of chronic TNFa to cd T cell dysfunction, we investigated whether skin cd T cell responses to tissue damage could be restored in vivo by treatment with neutralizing anti-TNFa antibody. 10-to 14-week old obese db/ db animals were treated daily for a minimum of four days with 1 mg/kg anti-TNFa or IgG control antibody. On day 4, fullthickness punch biopsy wounds were performed on each animal and epidermal cells were isolated around the wound edge 24 hours post-wounding. Skin cd T cells isolated from obese db/db animals treated with anti-TNFa antibody showed improved TGFb1 production as compared to db/db animals treated with IgG control antibody ( Figure 7E ). Similar rescue of TNFa production was observed in skin cd T cells isolated from db/db animals treated with anti-TNFa ( Figure 7F) . A significant improvement in skin cd T cell function at the wound site suggests that chronic inflammatory conditions, specifically in the form of TNFa, contributes to skin cd T cell hyporesponsiveness to in vivo wounding in obesity and metabolic disease.
Discussion
Skin cd T cells contribute to homeostatic maintenance of the epidermis and respond early to epithelial damage. Skin complications associated with obesity, metabolic disease and type 2 diabetes include barrier dysfunction, chronic non-healing wounds and increased infection. Due to their role in epidermal homeostasis and early response to keratinocyte damage, we investigated whether skin cd T cell are functional in mouse models of obesity and metabolic disease. Strikingly, we observed a biphasic progression of epidermal T cell dysfunction and the parameters responsible for each phase of T cell dysfunction were distinct. Hyperglycemia impacted early skin cd T cell proliferation and homeostasis, ultimately resulting in reduced epidermal T cell numbers. Chronic inflammation, occurring later in metabolic disease, rendered skin cd T cells hyporesponsive to in vivo stimulation. In spite of this, skin cd T cell dysfunction was reversible as improved cytokine production to in vivo stimulation was restored by systemic anti-TNFa antibody treatment. To our knowledge, this is the first description correlating different stages of lymphocyte dysfunction to disease progression in obesity.
Nutrients, such as glucose, are critical for lymphocyte survival, proliferation, differentiation and function [41, 42] . Many growth factors, such as insulin, IGF-1 and members of the common c c cytokine family (IL-2, IL-4, IL-7, IL-15) increase glucose uptake and metabolism via signaling through the PI3K/Akt pathway [42] . For example, IL-7 signaling in lymphocytes results in STAT5 and PI3K/Akt activation-induced glucose uptake [43] . However, we report here that during the first phase of dysfunction, skin cd T cells are highly susceptible to alterations in glucose concentrations. Similarly, both ab T cells and B cells have been shown to exhibit reduced proliferation when exposed to elevated glucose concentrations in vitro [43] . This suggests that although glucose and other nutrients may be critical for lymphocyte homeostasis and function, a chronic overabundance of nutrients is detrimental to the maintenance of cd T cells in the epidermis.
Elevated glucose resulted in altered STAT5 phosphorylation after IL-2 stimulation in vitro and ultimately impaired cd T cell proliferation. STAT5A/B signaling is critical to cd T cells as mice deficient in STAT5A/B lack cd T cells [27] . The inability of glucose-treated cd T cells to phosphorylate STAT5B in response to IL-2 points directly to an effect on proliferation as mice expressing a constitutively active STAT5B have an expanded cd T cell population [44] . Additionally, the severity of loss of skin cd T cells in BKS db/db mice correlates with a period of rapid expansion of cd T cells in the epidermis at 6-weeks of age. The hyperglycemic conditions during this seeding are severe in BKS db/db mice which may explain the sharp decrease in cd T cells.
Overall, these data demonstrate that skin cd T cells are highly sensitive to metabolic changes, such as hyperglycemia, in the cellular environment and respond to this stress by shutting down nutrient sensing pathways, such as cytokine and growth factor signal reception, resulting in decreased homeostatic proliferation and a reduced epidermal T cell compartment.
In the next phase of metabolic disease, skin cd T cells become unresponsive to tissue damage, resulting in reduced production of skin cd T cell cytokines and growth factors. Skin cd T cells are important mediators of inflammation and tissue repair as mice deficient in cd T cells (d 2/2 mice) exhibit delayed wound healing [1] . Additionally, skin-resident T cells in chronic wounds isolated from human patients do not upregulate growth factor production, which may contribute to the inability of chronic non-healing wounds to resolve [19] . In addition to the production of cytokines by skin cd T cells early in tissue damage, skin cd T cells also produce growth factors which are critical to skin homeostasis [16] . We observed a decrease in homeostatic TGFb1 production by skin cd T cells and an inability to upregulate TGFb1 following injury in obesity and metabolic disease. In the skin, the effects of TGFb1 antibody and 100 ng/ml TNFa. Three independent experiments were performed, a minimum of 10 fields were counted for each, and this data represents the average of all 35 fields and approximately 1000 total cells. (E, F) Fold change in MFI of (E) TGFb1 and (F) TNFa expression in skin cd T cells isolated from the wound edge compared to non-wound edge cells. Skin cd T cells from 10-to 14-week old BKS db/+ mice were used as a positive control, 10-to 14-week old db/db mice were either treated with 1 mg/kg IgG control antibody or anti-TNFa antibody for a minimum of four days. Shown in fold change in MFI for 3 separate experiments, significance was determined by t-test. doi:10.1371/journal.pone.0011422.g007
are broad and contribute to various aspects of wound healing including inflammation, angiogenesis, tissue remodeling and reepithelialization [45] . Altered TGFb1 production by skin cd T cells in obesity and metabolic disease may impact multiple phases of epidermal homeostasis and early and late stages of tissue repair.
To understand how the environment impacts the ability of skin cd T cells to respond to in vivo damage, we performed microarray analysis to investigate alterations in gene expression and found an increase in expression of molecules involved in TNFa signaling. In primary cells, TNFa induces NF-kB but not cell death pathways, and chronic TNFa would predictably result in chronic NF-kB activation, gene expression and survival [39] . This persistent activation leads to the induction of reactive oxygen species [39] , which can attenuate T cell responses [46, 47] , and uncouple TCR signal transduction, resulting in lower cell surface expression of the TCR/CD3 complex [48] . This supports our observation that cell surface cd TCR expression is decreased and downstream molecules regulating survival and negative feedback of NF-kB signaling were altered in skin cd T cells isolated from obese mice.
In addition, chronic TNFa and persistent NF-kB activation negatively impact other cell signaling pathways, including PI3K/ Akt/mTOR signaling [36, 49, 50] . TNFa and NF-kB suppress TSC1 inhibition of mTORC1, resulting in hyperactive mTORC1 activity, which contributes to insulin resistance [50] . Recently, mTORC1 has been shown to negatively inhibit mTORC2 signaling, a necessary complex for Akt activation, and may negatively inhibit growth factor signaling in pathways that don't require IRS-1 [51] . Furthermore, knockdown or deletion of mTORC2 complex molecules, including Rictor, Sin1 and Gbl, result in defective mTORC2 complex assembly and Akt activation [52, 53, 54] . Both mTORC1 and mTORC2 have been shown to be critical for skin cd T cell homeostasis and in vivo wound healing response [36] . Chronic TNFa stimulation of skin cd T cells results in direct effects, including alterations in TCR expression, and effects on other signaling pathways, including mTOR and Akt. These alterations in signaling ultimately render epidermal T cells hyporesponsive to barrier tissue disruption and keratinocyte damage.
Together, our data demonstrate that obesity and metabolic disease negatively impact the homeostasis and wound healing functions of cd T cells located in the epidermal barrier. The impact of chronic TNFa on cd T cells was reversible, suggesting that therapeutic strategies targeting the inflammatory environment and cd T cell dysfunction may provide additional treatments for complications associated with obesity, metabolic disease and type 2 diabetes. In addition to the skin, intraepithelial cd T cells reside in multiple barrier tissue locations, including the lung and intestinal tract, and the impact of metabolic disease on the function of other resident cd T cell populations is unknown. The consequence of reduced numbers and unresponsiveness of cd T cells in multiple barrier tissues would result in compromised ability to protect against damage or environmental insults and increased susceptibility to infection. This study demonstrates a previously unrecognized biphasic progression of skin cd T cell dysfunction in obesity and metabolic disease, in which hyperglycemia impacts skin cd T cell proliferation and homeostasis and chronic inflammatory mediators alter skin cd T cell response to barrier damage.
Materials and Methods
Ethics Statement
All animals were handled in strict accordance with good animal practice as defined by the relevant national and/or local animal welfare bodies. All animal work was approved by The Scripps Research Institute Institutional Animal Care and Use Committee (protocol 08-0057).
Mice
Wild-type C57BLKS/J, BKS-Lepr db heterozygous (C57BLKS/J db/+), and B6-Lepr db heterozygous (C57BL/6J db/+) mice were purchased from The Jackson Laboratory (Bar Harbor) and were housed and bred at The Scripps Research Institute (TSRI). Wildtype C57BL/6J mice were bred at TSRI Rodent Breeding Colony. For high fat diet experiments, wild-type male C57BL/6J mice were placed on a 60 kcal% fat diet (Research Diets) at 6 weeks of age, control mice were maintained on a 5 kcal% (Harlan Laboratory) or a 10 kcal% (Research Diets) diet. To generate d 2/2 db/db mice, C57BL/6J d 2/2 were crossed with C57BL/6J db/+ mice to generate d 2/2 db/+ mice. All mice were periodically weighed and blood glucose monitored by an Ascensia Elite XL blood glucose monitor (Bayer). BKS db/+ and db/db mice were assayed at 6 weeks and at 10-and 14-weeks of age. For HFD experiments, mice were assayed after 20 to 26 weeks on HFD. Mice were given access to food and water ad libitum and were housed in sanitized conditions.
Flow cytometry
FITC-, PE-, or allophycocyanin-conjugated monoclonal antibodies specific for cd TCR (GL3), Vc3 + (536), CD25 (PC61), TNFa (MP6-XT22), CD45.2, IL-4Ra and Thy1.2 (53.2.1) were purchased from BD Biosciences, CD69 (H1.2F3), CD103, CD3e, and Langerin antibodies were purchased from eBioscience, and TGFb1 was purchased from R&D Systems. The BD Bioscience Cytofix/Cytoperm kit was used for intracellular staining and Annexin-V/PI kit for flow cytometry. Cells were acquired with DiVa 5.0 software on a Digital LSRII (BD Biosciences) and analyzed with FlowJo software (Tree Star, Inc.). For FACS plots, gating was determined for each individual experiment using negative or isotype controls.
In vitro cd 7-17 cell line
The skin cd T-cell line 7-17 was maintained in complete RPMI (Mediatech, Inc.) supplemented with 10% heat-inactivated FBS and 20U/ml IL-2. For proliferation studies, 7-17 cells were plated at 1610 5 cells per well in a 96 well flat bottom plate in IL-2 containing growth media with either glucose (MediaTech) or fatty acids (palmitic acid, oleic acid and linoleic acid (Sigma)). Cells were pulsed with 1 mCi/well [ 3 H]thymidine (MP Biomedicals), harvested and incorporation of radioactive material was determined using a b-counter (Beckman). Fatty acids were prepared for cell culture assays as described elsewhere [55] . For analysis of phosphorylated STAT5A and STAT5B, 7-17 cells were pretreated with starvation media for 4 hours, then placed into IL-2 containing growth media supplemented with 33.3 mM glucose for 24 hours. Cells were starved for additional 4 hours +/2 glucose, followed by treatment with 40U/ml IL-2. Cells were lysed in TritonX Lysis Buffer, analyzed by Western blot using antibodies against phosphorylated STAT5A/STAT5B (Tyr 694 ) and total STAT5 (Cell Signaling), probed with secondary goat anti-rabbit IgG-HRP (Southern Biotech) and developed with Super Signal West Pico Chemiluminescence Kit (Thermo Scientific).
Epidermal cell preparation
Epidermal cells were isolated from mouse skin as described previously [1, 37] and rested at 37uC for 3-16 hours followed by antibody staining and flow cytometric analysis. For in vitro stimulation experiments, epidermal cells were isolated from mouse epidermis and placed into culture in complete DMEM media (Mediatech, Inc.) supplemented with 10% heat-inactivated FBS (Omega Scientific) and stimulated overnight with pre-coated anti-CD3e antibody at 1 mg/ml. Approximately 16 to 18 hours after culturing, cells were treated with 5 mg/ml brefeldin A (Sigma) for 4 hours at 37uC, isolated and stained intracellularly with antibodies for flow cytometry. All cells were cultured at 37uC and 5% CO 2 .
Freshly isolated cd T cells
Epidermal cell preparations were prepared from wild-type C57BL/6J mice as described above, and cd T cells were sorted on a FACSAria (TSRI Flow Cytometry Lab) based on anti-Thy1.2 antibody staining to a minimum of 95% purity. Skin cd T cells were collected into FCS, spun down and placed directly into 96 well round bottom plates in normal growth media (cRPMI with 10% FBS and 100U/ml IL-2) with baseline (11.1 mM) or elevated (33.3 mM) glucose. Cell proliferation was based on [ 3 H] thymidine incorporation as described above.
BrdU treatment in vivo
Mice were given a one time i.p. injection of 3.3 mg/ml BrdU (Sigma) in PBS, followed by 7 days of BrdU in their drinking water at 0.8 mg/ml. Mice were euthanized on day 8 and epidermal cells were isolated as described above. BrdU incorporation was detected by using the FITC BrdU Flow Kit (BD Biosciences).
Epidermal ear sheet and whole skin immunofluorescence
Epidermal sheets were isolated and stained as described previously [1, 37] . For in vitro stimulation assays, ears were removed from control db/+ animals, separated in half and floated on DMEM media (supplemented with 10% FBS) and treated with 10 mg/ml anti-CD3e antibody or 100 ng/ml recombinant TNFa (R&D Systems) as indicated. After indicated incubation at 37uC, ear sheet halves were removed, the epidermal sheet was separated from the dermis using ammonium thiocyanate and staining was performed. To visualize cross-sections of mouse skin, whole skin tissue was embedded in O.C.T. compound (Tissue-Tek), and 10 mm skin sections were cut on a Leica Cryostat. Sections were fixed with 4% paraformaldehyde for 10 minutes, and immunostained with cd TCR and CD3e antibodies. DAPI was used to counterstain the sections. Digital images were acquired (Zeiss AxioCam HRc) and analyzed using Photoshop CS2 software (Adobe). At least three separate experiments were performed for each time point and a minimum of 500 cells were quantified per experiment.
Animal dorsal and ear wounding protocols
Full-thickness biopsy punch wounds were performed on the dorsal surface and ears of mice as previously described [1, 14] . At the indicated time after wounding, mice were euthanized and wounds were harvested. Epidermal sheets were isolated for analysis of cd T cell rounding at the wound site by immunofluorescent microscopy. Epidermal cells were isolated using trypsin as described above, allowed to rest three hours in the presence of 5 mg/ml brefeldin A at 37uC, and followed by intracellular antibody staining for TNFa and/or TGFb1 expression and analysis by flow cytometry. For anti-TNFa treatment, obese db/db animals were randomly assigned to a treatment group, then weighed and blood glucose determined before the start of experiment. Mice received 1 mg/kg either anti-TNFa or IgG control antibody (Biolegend) each day i.p. for a minimum of 4 days total. On the final day of treatment, mice were euthanized and full-thickness punch biopsy wounds were administered as described above. Non-wounded skin and skin at the wound edge was removed 24 hours post-wounding and epidermal cells were isolated and stained for intracellular cytokine production as described above.
Microarray analysis
Epidermal cell preparations from mice were isolated and skin cd T cells were sorted on a FACSAria as described above. Skin cd T cells were collected directly into TRIzol LS reagent (Invitrogen), RNA was immediately isolated using the Qiagen RNeasy Micro RNA Kit and submitted to the TSRI DNA Array Core. 100 ng product was processed with GeneChip Whole Transcript Sense Target Labeling Assay (Affymetrix) and cDNA was hybridized overnight to the Mouse Gene 1.0ST Array (two independent data sets for each sample). Chips were scanned using the Affymetrix GeneChip Scanner 3000 7G with default settings and a target intensity of 250 for scaling. Data normalization was performed using RMA Express 1.0 with quantile normalization, median polish and background adjustment. This data has been deposited in NCBI's Gene Expression Omnibus and is accessible through GEO Series accession number GSE22196.
PCR determination of Lep and Lepr isoforms (Ob-Ra and Ob-Rb)
RNA was isolated from primary sorted skin cd T cells or 7-17 cell lines with TRIzol reagent and transcribed into cDNA with reverse transcriptase (Invitrogen). 1 ml cDNA was amplified using PCR with primers directed against Ob-Ra and Ob-Rb for 35 cycles [56] , leptin for 30 cycles [57] and b-actin controls [1] . A plasmid containing leptin cDNA was kindly provided by Dr. Luc Teyton (The Scripps Research Institute, La Jolla).
Lymph node staining
Lymph nodes were isolated from mice and pooled. Cells were mechanically disrupted from the tissue by gently agitating between two frosted slides in DMEM. Cells were stained for flow cytometric analysis using antibodies listed above.
Statistic analysis
Data are presented as mean 6 SEM or mean 6 SD and significance was determined using the t-test function of Microsoft Excel (two-tailed). 
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